-transparent.png){kind=logo}
A new cell line, PPC-I, has been established from a specimen obtained from a patient with a poorly differentiated adenocarcinoma of the prostate. This is the first line of its type derived from a primary prostatic tumor site. PPC-I cells have become immortalized in culture, exhibit transformation parameters including relaxed growth factor requirements and anchorage-independent growth, and are highly tumorigenic in nude mice. Cytogenetic studies by G-banding revealed a grossly abnormal karyotype, with a modal chromosome number of 84, multiple marker chromosomes including both homogeneously staining regions and double minutes and clonal loss of chromosomes 3, 5, 10, 15 and Y.
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
December 1995,
International journal of oncology,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
July 2000,
Cancer genetics and cytogenetics,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
July 1993,
Biochemistry and molecular biology international,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
January 1982,
Hereditas,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
March 2000,
The Prostate,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
June 1992,
Cancer genetics and cytogenetics,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
January 1987,
Journal of cancer research and clinical oncology,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
January 1995,
Annals of clinical and laboratory science,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
May 2018,
Biotechnology progress,
A R Brothman, and
L J Lesho, and
K D Somers, and
G L Wright, and
D J Merchant
October 1990,
Cancer genetics and cytogenetics,
